CliffBio
small molecule

MORPHABOND ER

MORPHINE SULFATE

Loss of exclusivityAugust 2028latest FDA-listed patent expiry
CompanyOHEMO LIFE SCIENCES INC

Drug detail

Brand nameMORPHABOND ER
Active ingredientMORPHINE SULFATE
Strength15MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2015
Marketing statusDISCN

Listed patents

PatentExpiresType
10314788August 2028product
7955619August 2028product

More from OHEMO LIFE SCIENCES INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MORPHABOND ER patent cliff — loss of exclusivity August 2028 | CliffBio